Gilead Sciences, Inc. recalls Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc.

Recalled May 22, 2013 · FDA recall D-324-2013 · Gilead Sciences

Hazard

Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection). · FDA Class I

Units

3,181 vials

Sold at

Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.

Description

Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).

Product

Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.

Manufacturer(s)

Gilead Sciences, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →